Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, June 7 '25)

Image
By G.M.

 


    Ann Intern Med

  1. MARCUCCI M, Chan MTV, Painter TW, Efremov S, et al
    Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-24-02841.
    PubMed         Abstract available

  2. GOLDMAN JM, Moyer DV
    Flying the Plane While Building It: Lessons From the COVID-19 Pandemic.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-02436.
    PubMed        


    Antiviral Res

  3. MALUNE P, Esposito F, Tramontano E
    Unveiling SARS-CoV-2's heart: role, structure and inhibition of SARS-CoV-2 RNA-dependent RNA polymerase.
    Antiviral Res. 2025 Jun 3:106208. doi: 10.1016/j.antiviral.2025.106208.
    PubMed         Abstract available


    BMJ

  4. MURPHY F
    Covid-19: New variant spreading across Asia is found in UK.
    BMJ. 2025;389:r1161.
    PubMed        

  5. LOOI MK
    Trump watch: Confusion over covid-19 vaccination, HIV vaccine funding withdrawn, and more.
    BMJ. 2025;389:r1145.
    PubMed        


    Clin Infect Dis

  6. POWERS LA, Chan AK, Wattengel BA, Davis M, et al
    Secondary Pneumococcal Disease in Veterans with Viral Respiratory Infections.
    Clin Infect Dis. 2025 May 31:ciaf285. doi: 10.1093.
    PubMed         Abstract available

  7. XHAFERI A, Bino S, Daja R, Vasili A, et al
    Sociodemographic and Occupational Factors Associated With Coronavirus Disease 2019 Vaccine and Influenza Vaccine Uptake Among Healthcare Workers, in Albania, 2022-2023: A Multicenter Study.
    Clin Infect Dis. 2025 Jun 3:ciaf202. doi: 10.1093.
    PubMed         Abstract available


    Graefes Arch Clin Exp Ophthalmol

  8. HILELY A, Barequet D, Ekshtein A, Levian L, et al
    Impact of the COVID-19 pandemic lockdowns on manifest refraction in a young adult population: A large cohort study.
    Graefes Arch Clin Exp Ophthalmol. 2025 Jun 4. doi: 10.1007/s00417-025-06862.
    PubMed         Abstract available


    J Med Virol

  9. LEE JE, Jo H, Cho H, Oh J, et al
    Global and Regional Burden of Vaccine-Associated Transverse Myelitis and Potentially Associated With Vaccines From 1967 to 2023: An Analysis of the International Pharmacovigilance Data.
    J Med Virol. 2025;97:e70408.
    PubMed         Abstract available

  10. YU J, Ju Y, Kim DK, Qian A, et al
    Changes in the Epidemiology of High-Risk HPV Genital Tract Infections Among Women in Shanghai: A Pre- and Post-COVID-19 Pandemic Analysis (2013-2024).
    J Med Virol. 2025;97:e70424.
    PubMed         Abstract available

  11. LEE S, Lee NK, Lee SW, Kim YJ, et al
    Changes in the Nationwide Incidence of Bell's Palsy in the General Population Before and After the COVID-19 Pandemic: An Ecological Study.
    J Med Virol. 2025;97:e70431.
    PubMed         Abstract available

  12. RAHMATI M, Udeh R, Kang J, Dolja-Gore X, et al
    Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of Symptoms 3 Years Post-SARS-CoV-2 Infection.
    J Med Virol. 2025;97:e70429.
    PubMed         Abstract available

  13. YUAN M, Wassef A, Sargsyan D, Nersisyan V, et al
    Genetic and Inflammatory Signatures Associated With Worse Prognosis in Hospitalized Patients With Severe SARS-CoV-2 Infection With and Without Diabetes.
    J Med Virol. 2025;97:e70425.
    PubMed         Abstract available


    J Virol

  14. LI Y, Duan L, Tang L, Huang M, et al
    Rapid reconstruction of infectious bronchitis virus expressing fluorescent protein from its nsp2 gene based on transformation-associated recombination platform.
    J Virol. 2025 Jun 5:e0053525. doi: 10.1128/jvi.00535.
    PubMed         Abstract available

  15. NGUYEN D, Laidlaw SM, Dong X, Wand M, et al
    SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.
    J Virol. 2025 Jun 4:e0051925. doi: 10.1128/jvi.00519.
    PubMed         Abstract available


    JAMA

  16. NGUYEN T, Whaley C, Simon KI, Cantor J, et al
    Health Care Workforce Recovery After the End of the COVID-19 Emergency.
    JAMA. 2025 Jun 5. doi: 10.1001/jama.2025.8588.
    PubMed        


    Lancet

  17. KAZATCHKINE M, Liden J
    Seeking an inclusive and just way to simplify the global health architecture.
    Lancet. 2025 May 29:S0140-6736(25)01100-6. doi: 10.1016/S0140-6736(25)01100.
    PubMed        


    Lancet Infect Dis

  18. VENTO S
    COVID-19 mortality in Africa and Asia.
    Lancet Infect Dis. 2025 May 29:S1473-3099(25)00348.
    PubMed        

  19. BEJON P, Agweyu A, Oyier I, Hamaluba M, et al
    COVID-19 mortality in Africa and Asia - Authors' reply.
    Lancet Infect Dis. 2025 May 29:S1473-3099(25)00350.
    PubMed        


    Nature

  20. WU MCL, Italiano E, Jarvis-Child R, Alwis I, et al
    Ischaemic endothelial necroptosis induces haemolysis and COVID-19 angiopathy.
    Nature. 2025 Jun 4. doi: 10.1038/s41586-025-09076.
    PubMed         Abstract available

  21. QIU J
    Exclusive: Inside the thriving wild-animal markets that could start the next pandemic.
    Nature. 2025;642:26-28.
    PubMed        


    Science

  22. SEQUEIRA AMM, Rodriguez JP, Marley SA, Calich HJ, et al
    Global tracking of marine megafauna space use reveals how to achieve conservation targets.
    Science. 2025;388:1086-1097.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »